Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Incyte corporation symbols : GSK save search
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $360.11 0.47% 0.47% 330K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
Myelofibrosis Treatment Market to Reach $1.16 Billion, Globally, by 2031 at 4.0% CAGR: Allied Market Research
Published: 2023-02-06 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.88%
H: 1.17%
C: -2.24%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.64%
H: 0.24%
C: -0.17%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.0%
H: 0.98%
C: 0.11%
AMRX | $5.42 1.12% 1.11% 1.1M
|
Health Technology
|
| O: 0.0%
H: 6.58%
C: 4.53%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.37%
H: 0.4%
C: -0.49%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 1.47%
C: 0.9%
GLTO | $0.72 4.71% 77K
|
Health Technology
|
| O: -1.11%
H: 3.36%
C: 1.12%
treatment research market
The Worldwide Alopecia Treatment Industry is Projected to Reach $6.2 Billion by 202
Published: 2023-01-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.52%
H: 1.79%
C: 1.73%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.58%
H: 0.39%
C: 0.03%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.24%
H: 1.21%
C: 1.07%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.1%
H: 2.05%
C: 0.82%
treatment
Melanoma to be the Most Promising Indication for the PD-1/PDL-1 Inhibitor Therapies in the U.S. and EU-5 Region - Exclusive DeepTech M-A-PTM Analysis by BIS Research
Published: 2022-10-07 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 6.33%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.63%
H: 0.76%
C: -0.26%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.14%
H: 0.16%
C: -0.91%
RCUS 4 | $14.59 -1.69% 0.0% 600K
|
Health Technology
|
| O: -1.93%
H: 0.53%
C: -5.94%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.72%
H: 0.38%
C: -1.04%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -1.78%
H: 1.45%
C: -2.55%
melanoma research
Vitiligo Treatment Market Size Worth US$ 2.42 Billion With CAGR of 6.14% from 2022 to 2030 | Exclusive Report by Growth Plus Reports
Published: 2022-09-05 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ALPMF | $9.17 43.47% 16K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
treatment report plus growth market
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
Published: 2022-06-16 (Crawled : 14:20) - biospace.com/
XLO | $1.16 -9.38% -10.34% 340K
|
Professional, Scientific, and T...
|
| O: 1.32%
H: 1.73%
C: -3.9%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.07%
H: 2.34%
C: 0.33%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
SNDX | $20.82 1.61% 1.59% 850K
|
Health Technology
|
| O: -2.65%
H: 0.76%
C: 0.06%
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: -1.96%
H: 0.67%
C: -5.33%
MRSN | $3.255 -2.55% -2.61% 2.4M
|
Health Technology
|
| O: -3.79%
H: 3.28%
C: 3.28%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: -1.32%
H: 0.01%
C: -5.65%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.17%
H: 1.76%
C: 1.46%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -4.37%
H: 0.14%
C: -3.76%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -4.31%
H: 0.9%
C: -8.11%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -2.0%
H: 0.29%
C: -0.93%
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
|
| O: -3.38%
H: 4.35%
C: -3.22%
therapeutics
Head and Neck Cancer Market worth $ 9.07 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-23 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.81%
H: 0.0%
C: -0.44%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -4.55%
H: 6.28%
C: 6.28%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: 0.0%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: -1.31%
H: 3.88%
C: -0.67%
KURA | $17.55 -0.74% -0.74% 1.3M
|
Health Technology
|
| O: -1.34%
H: 0.12%
C: -2.6%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.04%
H: 0.08%
C: -1.26%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.31%
H: 1.85%
C: 1.55%
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: -1.64%
H: 8.33%
C: 0.0%
CVM | $1.56 4.0% 0.0% 230K
|
Health Technology
|
| O: -0.92%
H: 2.31%
C: -3.47%
report cancer market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.